Gene therapy for the neurological manifestations in lysosomal storage disorders.

Gene therapy for the neurological manifestations in lysosomal storage disorders.

Item
http://www.wikidata.org/entity/Q38200599
Moving towards effective therapeutic strategies for Neuronal Ceroid LipofuscinosisTherapies for the bone in mucopolysaccharidosesA tailored mouse model of CLN2 disease: A nonsense mutant for testing personalized therapies.Levels of enzyme activities in six lysosomal storage diseases in Japanese neonates determined by liquid chromatography-tandem mass spectrometryCombination Therapies for Lysosomal Storage Diseases: A Complex Answer to a Simple Problem.Benzene and its metabolite decreases cell proliferation via LncRNA-OBFC2A-mediated anti-proliferation effect involving NOTCH1 and KLF15Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease.A canine model for neuronal ceroid lipofuscinosis highlights the promise of gene therapy for lysosomal storage diseases.
P2860

Gene therapy for the neurological manifestations in lysosomal storage disorders.

Item
http://www.wikidata.org/entity/Q38200599
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gene therapy for the neurological manifestations in lysosomal storage disorders.
@en
type
label
Gene therapy for the neurological manifestations in lysosomal storage disorders.
@en
prefLabel
Gene therapy for the neurological manifestations in lysosomal storage disorders.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Gene therapy for the neurological manifestations in lysosomal storage disorders.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932